razoxane has been researched along with acridines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciesielska, E; Denny, WA; Gniazdowski, M; Pastwa, E; Piestrzeniewicz, MK; Szmigiero, L | 1 |
| Hansen, HF; Jensen, LH; Jensen, PB; Nitiss, JL; Rothenborg-Jensen, L; Schmidt, G; Sehested, M; Wessel, I | 1 |
| Larsen, AK; Lemke, K; Poindessous, V; Skladanowski, A | 1 |
3 other study(ies) available for razoxane and acridines
| Article | Year |
|---|---|
Cytotoxic and DNA-damaging properties of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and its analogues.
Topics: Acridines; Animals; Antineoplastic Agents; DNA; DNA Damage; Enzyme Inhibitors; Etoposide; Mice; Razoxane; RNA; Topoisomerase II Inhibitors | 1998 |
Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Topics: Aclarubicin; Acridines; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport, Active; Cell Survival; Cross-Linking Reagents; DNA; DNA Damage; DNA Topoisomerases, Type II; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; In Vitro Techniques; Mutation; Podophyllotoxin; Polymerase Chain Reaction; Razoxane; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2001 |
The antitumor triazoloacridone C-1305 is a topoisomerase II poison with unusual properties.
Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Catalytic Domain; DNA; DNA Topoisomerases, Type II; Drug Interactions; Drug Screening Assays, Antitumor; Gene Expression; HL-60 Cells; Humans; Mice; Multidrug Resistance-Associated Proteins; NIH 3T3 Cells; Plasmids; Razoxane; Spheroids, Cellular; Time Factors; Topoisomerase II Inhibitors; Triazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2004 |